Lytix Biopharma appoints Stephen Worsley as Chief Business Officer

OSLO, Norway, Sept. 5, 2022 /PRNewswire/ — Lytix Biopharma (“Lytix”) (Euronext Growth Oslo: LYTIX), a Norwegian…